These results demonstrate the specific effects of the p53/Mdmx axis in lipid metabolism and adipose tissue remodeling and reveal a surprising role of Mdmx inhibition in anti-obesity effects beyond, commonly expected, tumor suppression. The gene discussed is MDM4; the disease is obesity due to melanocortin 4 receptor deficiency.